Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myeloid Hematological Malignancies × fludarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 9 Leukemia, Myeloid, Acute 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leukemia 5 Hodgkin Disease 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma 4 Hematologic Neoplasms 4 Recurrence 3 Primary Myelofibrosis 3 Myelodysplastic Syndromes 3 Lymphoma, Follicular 3 Anemia, Refractory, with Excess of Blasts 3 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Leukemia, Prolymphocytic 2 Leukemia, Plasma Cell 2 Burkitt Lymphoma 2 Thalassemia 1 Skin Neoplasms 1 Polycythemia Vera 1 Peritoneal Tumor 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myeloid Hematological Malignancies 1 Mesothelin-positive Advanced Malignant Solid Tumors 1

Interventions

fludarabine 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01247701 2022-06-08

UCAML

Baylor College of Medicine

Phase NA Completed

16 enrolled 14 charts

Myeloid Hematological Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡